Found: 47
Select item for more details and to access through your institution.
Endothelial cell control of thrombosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial.
- Published in:
- Acta Diabetologica, 2022, v. 59, n. 4, p. 575, doi. 10.1007/s00592-021-01823-6
- By:
- Publication type:
- Article
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials.
- Published in:
- BMC Surgery, 2015, v. 15, p. 1, doi. 10.1186/s12893-015-0096-z
- By:
- Publication type:
- Article
Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant.
- Published in:
- 2005
- By:
- Publication type:
- journal article
The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 5, p. 895, doi. 10.1093/ndt/gfz294
- By:
- Publication type:
- Article
Differential effects of 17 β-estradiol and testosterone on the contractile responses of porcine coronary arteries.
- Published in:
- British Journal of Pharmacology, 2000, v. 129, n. 7, p. 1301, doi. 10.1038/sj.bjp.0703164
- By:
- Publication type:
- Article
Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink‐6 randomized clinical trial.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02344-6
- By:
- Publication type:
- Article
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01849-w
- By:
- Publication type:
- Article
Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2021, v. 22, n. 4, p. 1171, doi. 10.1007/s11154-021-09669-7
- By:
- Publication type:
- Article
The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2765, doi. 10.1111/dom.15119
- By:
- Publication type:
- Article
NON-GENOMIC VASCULAR ACTIONS OF FEMALE SEX HORMONES: PHYSIOLOGICAL IMPLICATIONS AND SIGNALLING PATHWAYS.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2007, v. 34, n. 8, p. 822, doi. 10.1111/j.1440-1681.2007.04686.x
- By:
- Publication type:
- Article
ACUTE EXPOSURE TO A LOW LEVEL OF TESTOSTERONE IMPAIRS RELAXATION IN PORCINE CORONARY ARTERIES.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 1999, v. 26, n. 10, p. 830, doi. 10.1046/j.1440-1681.1999.03138.x
- By:
- Publication type:
- Article
ENDOTHELIAL DYSFUNCTION EXACERBATES THE IMPAIRMENT OF RELAXATION BY LYSOPHOSPHATIDYLCHOLINE IN PORCINE CORONARY ARTERY.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 1997, v. 24, n. 12, p. 984, doi. 10.1111/j.1440-1681.1997.tb02735.x
- By:
- Publication type:
- Article
Pedicled no-touch saphenous vein graft harvest limits vascular smooth muscle cell activation: the PATENT saphenous vein graft study†.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2014, v. 45, n. 4, p. 717, doi. 10.1093/ejcts/ezt560
- By:
- Publication type:
- Article
Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- BMC Cardiovascular Disorders, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12872-015-0068-3
- By:
- Publication type:
- Article
Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
- Published in:
- European Heart Journal, 2011, v. 32, n. 17, p. 2135, doi. 10.1093/eurheartj/ehr066
- By:
- Publication type:
- Article
Adiponectin and myocardial infarction: a paradox or a paradigm?
- Published in:
- European Heart Journal, 2006, v. 27, n. 19, p. 2266, doi. 10.1093/eurheartj/ehl248
- By:
- Publication type:
- Article
Acute impairment of relaxation by low levels of testosterone in porcine coronary arteries.
- Published in:
- Cardiovascular Research, 2000, v. 45, n. 4, p. 1010, doi. 10.1016/S0008-6363(99)00398-3
- By:
- Publication type:
- Article
Short-term exposure to physiological levels of 17β-estradiol enhances endothelium-independent relaxation in porcine coronary artery1.
- Published in:
- Cardiovascular Research, 1999, v. 42, n. 1, p. 224, doi. 10.1016/S0008-6363(98)00265-X
- By:
- Publication type:
- Article
Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Managing cardiometabolic risk in primary care.
- Published in:
- Canadian Family Physician / Médecin de Famille Canadien, 2012, v. 58, n. 4, p. 389
- By:
- Publication type:
- Article
Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity.
- Published in:
- Cardiovascular Research, 2023, v. 119, n. 18, p. 2858, doi. 10.1093/cvr/cvae016
- By:
- Publication type:
- Article
Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial.
- Published in:
- BMC Cardiovascular Disorders, 2023, v. 23, p. 1, doi. 10.1186/s12872-023-03549-5
- By:
- Publication type:
- Article
Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2015, v. 19, n. 3, p. 216, doi. 10.1177/1203475415576465
- By:
- Publication type:
- Article
Investigation of TGFβ1-Induced Long Noncoding RNAs in Endothelial Cells.
- Published in:
- International Journal of Vascular Medicine, 2016, p. 1, doi. 10.1155/2016/2459687
- By:
- Publication type:
- Article
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01390-8
- By:
- Publication type:
- Article
Empagliflozin restores the integrity of the endothelial glycocalyx in vitro.
- Published in:
- Molecular & Cellular Biochemistry, 2019, v. 459, n. 1/2, p. 121, doi. 10.1007/s11010-019-03555-2
- By:
- Publication type:
- Article
Cardiovascular inflammation is reduced with methotrexate in diabetes.
- Published in:
- Molecular & Cellular Biochemistry, 2017, v. 432, n. 1/2, p. 159, doi. 10.1007/s11010-017-3006-0
- By:
- Publication type:
- Article
Endothelial long non-coding RNAs regulated by oxidized LDL.
- Published in:
- Molecular & Cellular Biochemistry, 2017, v. 431, n. 1/2, p. 139, doi. 10.1007/s11010-017-2984-2
- By:
- Publication type:
- Article
Investigation of novel LPS-induced differentially expressed long non-coding RNAs in endothelial cells.
- Published in:
- Molecular & Cellular Biochemistry, 2016, v. 421, n. 1/2, p. 157, doi. 10.1007/s11010-016-2797-8
- By:
- Publication type:
- Article
IGFBP7 and left ventricular mass regression: a sub‐analysis of the EMPA‐HEART CardioLink‐6 randomized clinical trial.
- Published in:
- ESC Heart Failure, 2023, v. 10, n. 3, p. 2113, doi. 10.1002/ehf2.14335
- By:
- Publication type:
- Article
Impact of diabetes duration on left ventricular mass regression with empagliflozin.
- Published in:
- ESC Heart Failure, 2023, v. 10, n. 3, p. 2134, doi. 10.1002/ehf2.14357
- By:
- Publication type:
- Article
Baseline neutrophil‐to‐lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling.
- Published in:
- ESC Heart Failure, 2023, v. 10, n. 3, p. 2127, doi. 10.1002/ehf2.14351
- By:
- Publication type:
- Article
Stage‐based approach to predict left ventricular reverse remodeling after mitral repair.
- Published in:
- Clinical Cardiology, 2022, v. 45, n. 9, p. 921, doi. 10.1002/clc.23879
- By:
- Publication type:
- Article
Statin Effects on LDL and HDL Cholesterol in South Asian and White Populations.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 7, p. 831, doi. 10.1177/0091270009334376
- By:
- Publication type:
- Article
A global profile of glucose-sensitive endothelial-expressed long non-coding RNAs.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2016, v. 94, n. 9, p. 1007, doi. 10.1139/cjpp-2015-0585
- By:
- Publication type:
- Article
Effects of long-term chloroquine administration on the natural history of aortic aneurysms in mice.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2015, v. 93, n. 8, p. 641, doi. 10.1139/cjpp-2015-0068
- By:
- Publication type:
- Article
Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial?
- Published in:
- 2016
- By:
- Publication type:
- Letter
Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial.
- Published in:
- Diabetes Care, 2015, v. 38, n. 6, p. 1145, doi. 10.2337/dc14-2868
- By:
- Publication type:
- Article
Should A1C targets be individualized for all people with diabetes? Arguments for and against.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Should C-reactive protein be a target of therapy?
- Published in:
- 2011
- By:
- Publication type:
- journal article
Should A1C Targets Be Individualized for All People With Diabetes?
- Published in:
- Diabetes Care, 2011, v. 34, p. S191, doi. 10.2337/dc11-s217
- By:
- Publication type:
- Article
Should C-Reactive Protein Be a Target of Therapy?
- Published in:
- Diabetes Care, 2011, v. 34, p. S155, doi. 10.2337/dc11-s211
- By:
- Publication type:
- Article
Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI).
- Published in:
- 2010
- By:
- Publication type:
- journal article
Patient Age, Ethnicity, Medical History, and Risk Factor Profile, but Not Drug Insurance Coverage, Predict Successful Attainment of Glycemic Targets.
- Published in:
- Diabetes Care, 2010, v. 33, n. 12, p. 2558, doi. 10.2337/dc10-0440
- By:
- Publication type:
- Article